title: Markesbery disease: autosomal dominant late-onset distal myopathy: from phenotype to ZASP gene identification.
abstract: In 1974, Markesbery et al. thoroughly characterized and reported a large kindred with distal muscle weakness of late adult-onset that was autosomal dominantly inherited. Clinical evidence supported myopathy rather than the usual neuropathy expected with distal weakness. Postmortem examination of two patients documented myopathy and excluded anterior horn cell disease or peripheral neuropathy as the cause. Distinctive morphologic changes were present in muscle. Widely accepted as a distinct disease entity, this disorder has recently been characterized as one of a group of myofibrillar myopathies resulting from mutations in several muscle proteins. Studies of members of the original family have now identified the molecular defect to be a mutation in ZASP, Z-band alternatively spliced PDZ-motif-containing protein. The specific mutation, A165V, was identified in all clinical affected family members by direct sequencing. Thus, Markesbery disease is a zaspopathy. Other families have been identified with the same mutation and a shared haplotype indicating a founder effect.
authors.affiliation: Department of Neurology, University of Rochester School of Medicine and Dentistry, 1351 Mt. Hope Avenue, Suite 203, Rochester, NY 14620, USA. Robert_Griggs@URMC.Rochester.edu
authors.forename: Robert C
authors.initials: RC
authors.lastname: Griggs
authors.forename: Bjarne A
authors.initials: BA
authors.lastname: Udd
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D000328:Adult; D017668:Age of Onset; D049310:Distal Myopathies / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D060588:LIM Domain Proteins; D008279:Magnetic Resonance Imaging; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D010641:Phenotype
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C120696:LDB3 protein, human; D060588:LIM Domain Proteins
references.citation: Cell. 2002 Dec 27;111(7):943-55
references.pmid: 12507422
references.citation: Exp Cell Res. 2006 May 1;312(8):1299-311
references.pmid: 16476425
references.citation: J Biol Chem. 2004 Feb 20;279(8):6746-52
references.pmid: 14660611
references.citation: J Am Coll Cardiol. 2003 Dec 3;42(11):2014-27
references.pmid: 14662268
references.citation: Brain. 2007 Jun;130(Pt 6):1477-84
references.pmid: 17337483
references.citation: Ann Neurol. 2005 Feb;57(2):269-76
references.pmid: 15668942
references.citation: J Biol Chem. 2003 Feb 28;278(9):7360-5
references.pmid: 12499364
references.citation: Neurology. 1977 Aug;27(8):727-35
references.pmid: 196233
references.citation: Neurology. 2004 Apr 27;62(8):1363-71
references.pmid: 15111675
references.citation: Acta Med Scand Suppl. 1951;265:1-124
references.pmid: 14894174
references.citation: Neurology. 1974 Feb;24(2):127-34
references.pmid: 4855680
references.citation: Neuromuscul Disord. 2006 Jul;16(7):427-31
references.pmid: 16793270
references.citation: Structure. 2004 Apr;12(4):611-22
references.pmid: 15062084
references.citation: Arch Neurol. 1993 Jun;50(6):604-8
references.pmid: 8503797
references.citation: J Neurol Sci. 1981 Jul;51(1):141-55
references.pmid: 7252518